Related Experiment Video

Updated: May 31, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-κB and MAP kinases in

Yu Geng1, Marong Fang, Jing Wang

  • 1Department of Neurology, Zhejiang Province People's Hospital, Hangzhou, China.

Phytotherapy Research : PTR
|July 1, 2011
PubMed

Insights

Triptolide (TP) may protect neurons by inhibiting inflammatory molecules like COX-2 and blocking key pathways. This research explores TP

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Triptolide (TP), from Tripterygium wilfordii, has known anti-inflammatory and immunosuppressive effects.
  • TP shows promise in preventing dopaminergic neuron loss in Parkinson's disease models.
  • The precise neuroprotective mechanisms of TP remain largely unknown.

Purpose of the Study:

  • To investigate if TP's neuroprotection involves direct inhibition of inflammatory molecules.
  • To examine TP's effects on cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) expression.
  • To elucidate TP's impact on the nuclear factor-kappa B (NF-κB) pathway in neuronal cells.

Main Methods:

  • Utilized lipopolysaccharide (LPS)-stimulated PC12 cells.
  • Assessed mRNA and protein expression of COX-2 using real-time PCR and Western blotting.
  • Measured PGE2 production via ELISA and analyzed NF-κB, p38, ERK1/2, and AKT activation.

Main Results:

  • TP significantly inhibited both COX-2 mRNA and protein expression in a dose-dependent manner.
  • TP reduced PGE2 production and down-regulated NF-κB activity.
  • TP suppressed the phosphorylation of p38, ERK1/2, and AKT signaling pathways.

Conclusions:

  • TP's neuroprotective effects may stem from direct inhibition of COX-2 expression.
  • TP modulates the NF-κB pathway, suggesting a role in neuroinflammation.
  • TP influences key signaling cascades (p38, ERK1/2, AKT), contributing to its neuroprotective potential.

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...